Overall rank by patents
#4,867
of 49,997 tracked assignees
USPTO PatentsView assignee record - 71 granted patents across 17 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Bionime ranks #4,867 of 49,997 tracked US assignees by granted-patent volume, with 71 patents across 17 technology areas.
USPTO PatentsView assignee plate
Corpus R4867 · Foreign Corporation #4,867 · 71 grants
GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Avinger, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Armaments Research · near
56 score
Asml Holding · near
56 score
Bionime · this assignee
56 score
Holtec International · near
56 score
Soliton · near
56 score
3D Lighting… · lowest
7 score
What this shows Bionime's Innovation Score is 56.3/100 (top 6% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Bionime Corporation is a focused PatentsView assignee: 17 CPC subclasses with 63.4% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2024 (14 grants) versus a trough of 2 in 2017. By volume, Bionime sits between Avinger, Inc. and Changzhou Patent Electronic Technology Co., Ltd.
Bionime Corporation shows 36 grants in 2022–2024 against only 11 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Avinger, Inc.
71 patents
Bandai Co. Ltd
71 patents
Basf Agro B.V.
71 patents
Beto Engineering & Marketing Co., Ltd.
71 patents
Bedford Industries, Inc.
71 patents
Blast Motion Inc.
71 patents
Bunn-O-Matic Corporation
71 patents
Changzhou Patent Electronic Technology Co., Ltd
71 patents
Bionime Corporation
71 patents
What this shows Bionime holds 71 patents at rank #4,866, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #4,866 in granted patent volume.
Other assignees with the most granted patents in Bionime's primary technology class.
Two PlainPatent-derived peer sets for Bionime, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (56 here).
Nearest assignees by average claims per patent (11.6 here).
Bionime's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
56 Top 6% higher than 94% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 7 | 9.9% |
| 2016 | 3 | 4.2% |
| 2017 | 2 | 2.8% |
| 2019 | 3 | 4.2% |
| 2020 | 4 | 5.6% |
| 2021 | 4 | 5.6% |
| 2022 | 11 | 15.5% |
| 2023 | 11 | 15.5% |
| 2024 | 14 | 19.7% |
| 2025partial year | 12 | 16.9% |
Top 15 of 17 technology areas
Overall rank by patents
#4,867
of 49,997 tracked assignees
56.3 out of 100
What to do with this data
Bionime Corporation's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.